Skip to content

Reshaping rare cancer drug discovery

April 2023

Our Head of Oncology Dr Alessandro Carugo features in a Drug Discovery World’s Cancer Research Guide, where he explains why building expert alliances, and pursuing ambitious drug discovery strategies across multiple drug modalities, is key to addressing unmet needs in rare cancer drug discovery.

READ MORE

UNDER THE MICROSCOPE: EXPLORING PHAGE DISPLAY TECHNOLOGIES FOR DRUG DISCOVERY AND EARLY DEVELOPMENT

September 2022

With over 20 years’ of expertise in phage display, IRBM applies its extensive peptide and antibody libraries to discover lead therapeutic candidates.

DOWNLOAD

IRBM CSO CARLO TONIATTI ON THE EVOLVING CRO ROLE IN DRUG DEVELOPMENT, EMERGING APPROACHES IN ONCOLOGY & THE POTENTIAL OF AI

October 7 2021

Carlo Toniatti, chief scientific officer of IRBM, gives his insights into how the increased participation of early-stage ventures in the drug R&D process and the plethora of new research approaches that are recalibrating the role of CROs such as IRBM. An experienced oncologist, Toniatti also weighs in on the key emerging trends within the cancer field and assesses AI’s potential as a truly transformative asset within the drug developer’s toolbox.

Read more

DRUG HUNTERS DRIVEN BY A PASSION FOR SCIENCE

September 2021

Structural biology (SB) provides a critical drug discovery and development tool for accurately identifying and understanding the structure of a target. Alessandro Piai, PhD, Principal Research Scientist at IRBM, describes the company’s expertise in nuclear magnetic resonance (NMR) and how it can be leveraged to accelerate the identification of molecules for progression to the clinic.

DOWNLOAD

INTERVIEW WITH IRBM’S DR MARIA VENEZIANO ON PHARMACOKINETIC STUDIES

July 30 2020

At IRBM we are passionate about science, and love talking about what we do to advance drug discovery. One of our scientists, Dr Maria Veneziano, has been interviewed by the International Journal of Pharmacokinetics (IJP), about her extensive experience working on pharmacokinetic studies.

READ MORE

IRBM’S ELISABETTA BIANCHI TALKS ABOUT PEPTIDE CHEMISTRY

June 2019

This feature article in Chemistry Today, highlights our peptide chemistry team’s extensive expertise in peptide and macrocyclic drug discovery in a range of therapeutic areas and with an impressive track record in the clinic.

DOWNLOAD

PUBLICATIONS

FACTSHEETS

Back To Top